Clinical Trial Update: Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vaccine therapy with or without sargramostim after melanoma surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• sargramostim (sargramostim)
• vaccine therapy (unspecified)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma | Phase 2 | Status: COMPLETED